149 related articles for article (PubMed ID: 30298719)
21. Iodinated hyaluronic acid oligomer-based nanoassemblies for tumor-targeted drug delivery and cancer imaging.
Lee JY; Chung SJ; Cho HJ; Kim DD
Biomaterials; 2016 Apr; 85():218-31. PubMed ID: 26874284
[TBL] [Abstract][Full Text] [Related]
22. The antitumor effects of methyl-β-cyclodextrin against primary effusion lymphoma via the depletion of cholesterol from lipid rafts.
Gotoh K; Kariya R; Alam MM; Matsuda K; Hattori S; Maeda Y; Motoyama K; Kojima A; Arima H; Okada S
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):285-9. PubMed ID: 25446086
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronic acid conjugated β-cyclodextrin-oligoethylenimine star polymer for CD44-targeted gene delivery.
Yin H; Zhao F; Zhang D; Li J
Int J Pharm; 2015 Apr; 483(1-2):169-79. PubMed ID: 25681725
[TBL] [Abstract][Full Text] [Related]
24. Cholesterol homeostasis in T cells. Methyl-beta-cyclodextrin treatment results in equal loss of cholesterol from Triton X-100 soluble and insoluble fractions.
Mahammad S; Parmryd I
Biochim Biophys Acta; 2008 May; 1778(5):1251-8. PubMed ID: 18373974
[TBL] [Abstract][Full Text] [Related]
25. Dual targeting system by supramolecular complex of folate-conjugated methyl-β-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer.
Elamin KM; Motoyama K; Higashi T; Yamashita Y; Tokuda A; Arima H
Int J Biol Macromol; 2018 Jul; 113():386-394. PubMed ID: 29486262
[TBL] [Abstract][Full Text] [Related]
26. The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin.
Wang J; Ma W; Guo Q; Li Y; Hu Z; Zhu Z; Wang X; Zhao Y; Chai X; Tu P
Int J Nanomedicine; 2016; 11():5851-5870. PubMed ID: 27853369
[TBL] [Abstract][Full Text] [Related]
27. A novel double-targeted nondrug delivery system for targeting cancer stem cells.
Qiao S; Zhao Y; Geng S; Li Y; Hou X; Liu Y; Lin FH; Yao L; Tian W
Int J Nanomedicine; 2016; 11():6667-6678. PubMed ID: 27994463
[TBL] [Abstract][Full Text] [Related]
28. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
Sargazi A; Shiri F; Keikha S; Majd MH
Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
[TBL] [Abstract][Full Text] [Related]
30. Mitochondria Targeting and Destabilizing Hyaluronic Acid Derivative-Based Nanoparticles for the Delivery of Lapatinib to Triple-Negative Breast Cancer.
Lee SY; Cho HJ
Biomacromolecules; 2019 Feb; 20(2):835-845. PubMed ID: 30566834
[TBL] [Abstract][Full Text] [Related]
31. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Lee JH; Kim K; Kwon IC; Kim DD
Biomaterials; 2011 Oct; 32(29):7181-90. PubMed ID: 21733572
[TBL] [Abstract][Full Text] [Related]
32. Effects of methyl-beta-cyclodextrin-mediated cholesterol depletion in porcine sperm compared to somatic cells.
van Gestel RA; Helms JB; Brouwers JF; Gadella BM
Mol Reprod Dev; 2005 Nov; 72(3):386-95. PubMed ID: 16044473
[TBL] [Abstract][Full Text] [Related]
33. Nanocomplexes based on amphiphilic hyaluronic acid derivative and polyethylene glycol-lipid for ginsenoside rg3 delivery.
Lee JY; Yang H; Yoon IS; Kim SB; Ko SH; Shim JS; Sung SH; Cho HJ; Kim DD
J Pharm Sci; 2014 Oct; 103(10):3254-62. PubMed ID: 25112537
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery.
Park JH; Cho HJ; Yoon HY; Yoon IS; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD
J Control Release; 2014 Jan; 174():98-108. PubMed ID: 24280260
[TBL] [Abstract][Full Text] [Related]
35. Coating Solid Lipid Nanoparticles with Hyaluronic Acid Enhances Antitumor Activity against Melanoma Stem-like Cells.
Shen H; Shi S; Zhang Z; Gong T; Sun X
Theranostics; 2015; 5(7):755-71. PubMed ID: 25897340
[TBL] [Abstract][Full Text] [Related]
36. Lipid raft association restricts CD44-ezrin interaction and promotion of breast cancer cell migration.
Donatello S; Babina IS; Hazelwood LD; Hill AD; Nabi IR; Hopkins AM
Am J Pathol; 2012 Dec; 181(6):2172-87. PubMed ID: 23031255
[TBL] [Abstract][Full Text] [Related]
37. The use of methyl-β-cyclodextrin to solubilize cholesterol prior to coating onto a C18 stationary phase.
Charlton SA; Coym JW
J Chromatogr A; 2012 Nov; 1266():69-75. PubMed ID: 23107117
[TBL] [Abstract][Full Text] [Related]
38. A simple method for effective and safe removal of membrane cholesterol from lipid rafts in vascular endothelial cells: implications in oxidant-mediated lipid signaling.
Kline MA; O'Connor Butler ES; Hinzey A; Sliman S; Kotha SR; Marsh CB; Uppu RM; Parinandi NL
Methods Mol Biol; 2010; 610():201-11. PubMed ID: 20013180
[TBL] [Abstract][Full Text] [Related]
39. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS
Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
